Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
UNDERWOOD J, McKloskey S, Raldow A, Kishan A, Zalkin C, Navarro D, Holt LS, Webb A, Lynch KA, Atkinson TA
Developing a Mobile Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Administration System to Capture Postradiation Toxicity in Oncology: Usability and Feasibility Study
Developing a Mobile PRO-CTCAE Administration System to Capture Post-Radiation Toxicity in Oncology: A Usability and Feasibility Study
JODY UNDERWOOD;
Susan McKloskey;
Ann Raldow;
Amar Kishan;
Chad Zalkin;
Daniel Navarro;
Lisa Scott Holt;
Andrew Webb;
Kathleen A. Lynch;
Thomas A. Atkinson
ABSTRACT
Background:
Accurate self-reported symptomatic toxicity documentation via the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is essential throughout cancer treatment to ensure safety and understand therapeutic efficacy. However, the capture of accurate toxicities from patients undergoing radiation therapy is challenging since this is generally provided only at time of scheduled visits.
Objective:
This study seeks to establish the usability and feasibility of a mobile PRO-CTCAE administration system (mPROS) to capture toxicities related to radiation therapy.
Methods:
Adult, English-speaking patients who were undergoing radiation therapy for cancer were enrolled and given a brief demonstration of the mPROS Say All Your Symptoms (SAYS) and Symptom Tracking Entry Program (STEP) interfaces, followed by a participant use phase where patient actions were observed as they navigated mPROS to enter toxicities. Patient feedback was captured via a semi-structured interview and brief questionnaire.
Results:
Twenty-five patients (mean age=60.7; 52% female; 52% white; 76% non-Hispanic; 68% college graduate) were enrolled. Patients almost equally preferred SAYS (n=14; 56%) or STEP (n=11; 44%) interfaces, with 21 patients (84%) agreeing that they would use mPROS to report their symptoms to their healthcare team and 19 patients (76%) agreeing that they would recommend mPROS to others.
Conclusions:
mPROS is usable and feasible to facilitate patient reporting of radiation therapy-related symptomatic toxicities. A revised version of mPROS that incorporates patient input and includes electronic health record integration is being developed and validated as part of a multicenter trial. Clinical Trial: N/A
Citation
Please cite as:
UNDERWOOD J, McKloskey S, Raldow A, Kishan A, Zalkin C, Navarro D, Holt LS, Webb A, Lynch KA, Atkinson TA
Developing a Mobile Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Administration System to Capture Postradiation Toxicity in Oncology: Usability and Feasibility Study